Remedium Lifecare Performance Analyzed
Remedium Lifecare’s recent financial results paint a concerning picture. Sales dropped dramatically, falling 65.79% to just Rs 8.58 crore in the quarter ending September 2025. This is a significant decrease from the previous quarter’s sales of Rs 25.08 crore. The company’s profitability also suffered severely, leading to a substantial reduction in net profit.
Key Points
- Sales plummeted, down 66% to Rs 8.58 crore.
- Net profit decreased by 96% to Rs 0.07 crore.
- Operating profit margin significantly shrank to -34.85%.
- Product Below the Line Data (PBDT) fell to Rs 0.07 crore.
- Profit Before Tax (PBT) reduced to Rs 0.07 crore.
- Net Profit decreased to Rs 0.07 crore.
Financial Overview – September 2025
The key figures for the quarter ending September 2025 reveal a critical need for immediate action. Sales revenue totaled Rs 8.58 crore, a drastic drop compared to the prior quarter’s Rs 25.08 crore. This indicates a serious problem impacting the company’s revenue streams.
Profitability was equally poor. The Operating Profit Margin (OPM) decreased to -34.85%, showing extremely low profit generation. The Product Below the Line Data (PBDT) also decreased to Rs 0.07 crore, further highlighting the challenges faced.
Finally, the company’s Profit Before Tax (PBT) was only Rs 0.07 crore, and the Net Profit (NP) reached Rs 0.07 crore, demonstrating a complete inability to generate sustainable earnings.
These results demonstrate a need for a comprehensive review of Remedium Lifecare’s strategy and operations.
